Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionAltman Advisors, Inc.
Latest Disclosed Ownership21,992 shares
Latest Disclosed Value $ 3,065,057
Altman Advisors, Inc. reports 2.28% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 5, 2026 - Altman Advisors, Inc. filed a 13F-HR form disclosing ownership of 21,992 shares of Gilead Sciences, Inc. (CH:GILD) valued at $3,065,057 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 22,505 shares of Gilead Sciences, Inc.. This represents a change in shares of -2.28% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F GILEAD SCIENCES COM 375558103 21,992 -513 -2.28 3,065 10.97 1.2704
2026-02-04 2025-12-31 13F GILEAD SCIENCES COM 375558103 22,505 186 0.83 2,762 11.51 1.0408
2025-11-13 2025-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 22,319 333 1.51 2,477 0.86 0.9478
2025-11-07 2025-09-30 13F GILEAD SCIENCES COM 375558103 21,986 0 2,456 1.0053
2025-08-07 2025-06-30 13F GILEAD SCIENCES COM 375558103 21,986 716 3.37 2,456 8.38 1.0034
2025-05-02 2025-03-31 13F GILEAD SCIENCES COM 375558103 21,270 317 1.51 2,266 17.11 1.0442
2025-02-13 2024-12-31 13F GILEAD SCIENCES COM 375558103 20,953 78 0.37 1,935 10.57 0.8252
2024-11-08 2024-09-30 13F GILEAD SCIENCES COM 375558103 20,875 253 1.23 1,750 23.76 0.7787
2024-08-08 2024-06-30 13F GILEAD SCIENCES COM 375558103 20,622 554 2.76 1,415 -3.28 0.8044
2024-05-09 2024-03-31 13F GILEAD SCIENCES COM 375558103 20,068 877 4.57 1,463 -5.92 0.7119
2024-02-08 2023-12-31 13F GILEAD SCIENCES COM 375558103 19,191 -132 -0.68 1,555 7.32 0.8153
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 19,323 178 0.93 1,448 7.74 0.9038
2023-05-09 2023-03-31 13F GILEAD SCIENCES COM 375558103 19,145 364 1.94 1,345 -17.90 1.2307
2023-02-08 2022-12-31 13F GILEAD SCIENCES COM 375558103 18,781 -658 -3.38 1,638 36.53 1.0104
2022-11-08 2022-09-30 13F GILEAD SCIENCES COM 375558103 19,439 19,439 1,199 0.7569
2021-02-10 2020-12-31 13F GILEAD SCIENCES COM 375558103 0 -6,054 -100.00 0 -100.00
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 6,054 -24,723 -80.33 383 -83.83 0.2714
2020-08-12 2020-06-30 13F GILEAD SCIENCES COM 375558103 30,777 -75 -0.24 2,368 2.69 2.0130
2020-04-20 2020-03-31 13F GILEAD SCIENCES COM 375558103 30,852 30,852 2,306 2.1414
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.